- Home
- EQIX vs BMY Comparison
EQIX vs BMY Comparison
Compare EQIX & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQIX
- BMY
- Stock Information
- Founded
- EQIX 1998
- BMY 1887
- Country
- EQIX United States
- BMY United States
- Employees
- EQIX N/A
- BMY N/A
- Industry
- EQIX Real Estate Investment Trusts
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- EQIX Real Estate
- BMY Health Care
- Exchange
- EQIX Nasdaq
- BMY Nasdaq
- Market Cap
- EQIX 79.7B
- BMY 94.0B
- IPO Year
- EQIX 2000
- BMY N/A
- Fundamental
- Price
- EQIX $829.49
- BMY $45.60
- Analyst Decision
- EQIX Buy
- BMY Hold
- Analyst Count
- EQIX 21
- BMY 14
- Target Price
- EQIX $947.55
- BMY $57.54
- AVG Volume (30 Days)
- EQIX 492.4K
- BMY 16.3M
- Earning Date
- EQIX 10-29-2025
- BMY 10-30-2025
- Dividend Yield
- EQIX 2.26%
- BMY 5.44%
- EPS Growth
- EQIX N/A
- BMY N/A
- EPS
- EQIX 10.95
- BMY 2.97
- Revenue
- EQIX $9,076,000,000.00
- BMY $48,034,000,000.00
- Revenue This Year
- EQIX $8.10
- BMY N/A
- Revenue Next Year
- EQIX $8.67
- BMY N/A
- P/E Ratio
- EQIX $75.80
- BMY $15.35
- Revenue Growth
- EQIX 5.63
- BMY 1.26
- 52 Week Low
- EQIX $701.41
- BMY $42.52
- 52 Week High
- EQIX $994.03
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- EQIX 54.94
- BMY 56.29
- Support Level
- EQIX $821.17
- BMY $42.52
- Resistance Level
- EQIX $853.83
- BMY $46.66
- Average True Range (ATR)
- EQIX 20.03
- BMY 0.92
- MACD
- EQIX -0.10
- BMY 0.34
- Stochastic Oscillator
- EQIX 58.88
- BMY 74.40
About EQIX Equinix Inc. REIT
Equinix operates 260 data centers in 71 markets worldwide. It generates 44% of total revenue in the Americas, 35% in Europe, the Middle East, and Africa, and 21% in Asia-Pacific. The firm has more than 10,000 customers, including 2,100 network providers, across five verticals: cloud and IT services, content providers, network and mobile services, financial services, and enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from interconnection. Equinix operates as a real estate investment trust.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.